Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem?
Alessandra Iurlo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Agostino Cortelezzi(Istituti di Ricovero e Cura a Carattere Scientifico), Chiara Elena(Policlinico San Matteo Fondazione), Veronica Resi(University of Milan), Dario Consonni(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Mariarita Sciumé(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Nicola Orofino(Azienda Ospedaliera Ospedale Civile di Legnano), Emanuela Orsi(University of Milan), Valeria Grancini(University of Milan), Daniele Cattaneo(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Ester Orlandi(University of Pavia), Cristina Bucelli(University of Milan)
Cited by 67
Related Papers
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|The American Journal of Human Genetics|2009|510
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|The American Journal of Human Genetics|2011|506